Medicare Enrolled

Dr. Narciso Gonzalez, MD

Pain Medicine · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2130 NE LOOP 410 STE 375, San Antonio, TX 78217
2106341232
In practice since 2007 (18 years)
NPI: 1316128549 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gonzalez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gonzalez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gonzalez

Dr. Narciso Gonzalez is a pain medicine specialist in San Antonio, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Gonzalez performed 6,172 Medicare services across 1,821 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gonzalez received a total of $6,746 from 43 pharmaceutical and/or device companies across 443 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gonzalez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 9% volume in TX $6,746 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,172
Medicare services
Top 9% in TX for pain medicine
1,821
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~343 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid) 1,613 $0 $1
Office visit, established patient (30-39 min) 1,041 $91 $254
Drug screening test 817 $61 $162
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 798 $195 $402
Assessment of emotional or behavioral problems 400 $3 $17
Injection, ketorolac tromethamine, per 15 mg 187 $0 $2
Injection of drug or substance into vein 175 $28 $78
Office visit, established patient (20-29 min) 166 $67 $180
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes 160 $38 $99
Drug injection, under skin or into muscle 76 $10 $31
Fluoroscopic guidance for needle placement 67 $86 $180
Joint injection, major joint 64 $53 $157
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level 63 $245 $1,020
Injection of lower or sacral spine facet joint using imaging guidance, single level 61 $180 $699
Injection of lower or sacral spine facet joint using imaging guidance, second level 43 $97 $348
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes 43 $8 $22
Blood glucose (sugar) test performed by hand-held instrument 42 $3 $8
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint 36 $467 $1,641
Office visit, established patient (10-19 min) 36 $39 $110
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 33 $242 $513
Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance 32 $198 $645
Injection of trigger points, 3 or more muscles 31 $44 $140
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint 29 $257 $706
Injection of upper or middle spine facet joint using imaging guidance, single level 23 $199 $743
Ultrasound study of arm or leg veins with compression and maneuvers 23 $118 $382
Ultrasound of leg arteries or artery grafts 22 $176 $498
Injection of substance into lower spine canal using imaging guidance 18 $183 $758
New patient office visit (30-44 min) 17 $85 $221
Injection of substance into middle or upper spine canal using imaging guidance 16 $200 $758
New patient office visit (45-59 min) 15 $127 $379
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level 13 $92 $370
Injection, methylprednisolone acetate, 20 mg 12 $5 $9
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,746
Total received (2018-2024)
Avg $964/year across 7 years
Top 33% in TX for pain medicine
43
Companies
443
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,350 (94.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$396 (5.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$324
2023
$763
2022
$1,010
2021
$719
2020
$637
2019
$1,841
2018
$1,451

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,551
Boston Scientific Corporation
$1,074
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$624
BOSTON SCIENTIFIC CORPORATION
$568
Medtronic Vascular, Inc.
$399
Assertio Therapeutics, Inc.
$235
Collegium Pharmaceutical, Inc.
$193
SI-BONE, INC.
$168
ASSERTIO THERAPEUTICS, Inc.
$167
PFIZER INC.
$150
Scilex Pharmaceuticals Inc.
$126
SCILEX PHARMACEUTICALS INC.
$125
GlaxoSmithKline, LLC.
$119
Pernix Therapeutics Holdings, Inc.
$111
Nalu Medical, Inc.
$80
Horizon Therapeutics plc
$78
SI-BONE, Inc.
$77
Flexion Therapeutics, Inc.
$69
Daiichi Sankyo Inc.
$63
Almatica Pharma LLC
$59
Hikma Pharmaceuticals USA
$56
Bioventus LLC
$55
Medtronic, Inc.
$53
BioDelivery Sciences International, Inc.
$52
Biocompatibles, Inc.
$51
Vascular Insights, LLC
$46
Averitas Pharma Inc.
$42
FIDIA PHARMA USA INC.
$42
AstraZeneca Pharmaceuticals LP
$35
Azurity Pharmaceuticals, Inc.
$33
US WorldMeds, LLC
$32
Shionogi Inc
$32
GRT US Holding, Inc.
$30
Saluda Medical Americas, Inc.
$28
Novartis Pharmaceuticals Corporation
$20
Medtronic USA, Inc.
$17
Fidia Pharma USA Inc.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$13
RedHill Biopharma Inc.
$12
Stryker Corporation
$12
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$12
Zyla Life Sciences, Inc.
$11
Lilly USA, LLC
$11
Top 3 companies account for 48.2% of total payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AIMOVIG · Accurian · Amitiza · BELBUCA · BENLYSTA · BUNAVAIL 2.1 mg 30-count box · Belbuca · Cambia · Clarivein · ClosureFast · ClosureRFG · EMBEDA · EMBLEM MRI S-ICD · ETERNA · Evoke · FLECTOR · FORTEO · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GRALISE · General - Pain Management · Gralise · HYMOVIS · Horizant · Hymovis · IFUSE IMPLANT · Kloxxado · LYRICA · Lucemyra/Lofexidine · MOVANTIK · Morphabond ER · Movantik · NAPRELAN · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · PENNSAID · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · QUTENZA · Qutenza · RAYOS · RELISTOR · REYVOW · SCS IPGs · SPECTRA WAVEWRITER · SPINEJACK · SPRIX · SUPARTZ FX SODIUM HYALURONATE · Supartz FX Sodium Hyaluronate · Symproic · VARITHENA · Vanta · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $109 per 100 Medicare services performed
Looking for a pain medicine specialist in San Antonio?
Compare pain medicines in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
33
Per 100K population
1.6
County median income
$70,571
Nearest hospital
BAPTIST NEIGHBORHOOD HOSPITAL THOUSAND OAKS
4.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gonzalez is a clinical cardiology specialist, with above-average Medicare volume (top 9% in TX), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gonzalez experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Gonzalez performed 1,613 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gonzalez receive payments from pharmaceutical companies?
Yes. Dr. Gonzalez received a total of $6,746 from 43 companies across 443 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gonzalez's costs compare to other pain medicines in San Antonio?
Dr. Gonzalez's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gonzalez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →